DuPont’s Nutrition Business Spin-Off Through Subsidiaries Merger With IFF Moves Toward Closing
Executive Summary
IFF announces preliminary results of more than 99% of votes approving issuing shares pursuant to an agreement that positions it as acquiring DuPont Nutrition & Biosciences under a “reverse Morris trust” transaction. The merger is between DuPont Nutrition & Biosciences and a subsidiary IFF established as a corporate entity to conduct the transaction.
You may also be interested in...
IFF Plus DuPont N&B Equals $11.2Bn Revenues
"Now it's up to us to look where can we accelerate our portfolio, in which areas and where can we grow the most and deliver good value for our customers,” says CEO Andreas Fibig.
IFF Swings Open Door On Growing Probiotic Sales After Closing Merger With DuPont Nutrition
Two weeks after merging with probiotic ingredient leader DuPont Nutrition & Biosciences, International Flavors & Fragrances hosts first of two online conferences to help manufacturers and marketers “unlock the power of the microbiome wellness industry."
DuPont, P&G Aim To Accelerate Probiotic Sales By Developing ‘Next Generation’ Ingredients
DuPont says it and P&G “have conducted extensive research on human commensals bacteria to help address metabolic health issues in humans.” The partnership "will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world,” says Paul Gama, P&G personal health care president.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: